MicroRNAs associated with the mir-17-92 cluster are crucial regulators of the mammalian cell cycle, as they inhibit transcription factors related to the E2F family that tightly control decision-making events for a cell to commit for active cellular proliferation. Intriguingly, in many solid cancers, these mir-17-92 cluster members are overexpressed, whereas in some hematopoietic cancers they are down-regulated. Our proposed model of the Myc/E2F/mir-17-92 network demonstrates that the differential expression pattern of mir-17-92 in different cell types can be conceived due to having a contrasting E2F dynamics induced by mir-17-92. The model predicts that by explicitly altering the mir-17-92-related part of the network, experimentally it is possible to control cellular proliferation in a cell type-dependent manner for therapeutic intervention.
In mammalian cells, the expression levels of the key transcription factors E2F (mainly E2F1, E2F2, and E2F3) and Myc precisely govern the fate commitment of a mammalian cell toward either active cellular proliferation or quiescence under normal growth condition in the late G 1 phase of the cell cycle [1] [2] [3] [4] . Experimentally, it had been elegantly demonstrated that the expression level of the E2F1 protein follows a bistable dynamics (involving E2F1 and Myc) as a function of growth factor (GF) [1] . This implies that based on the expression levels of E2F1 in the late G 1 phase, the mammalian cells can either opt for a quiescence state (Off state, low E2F1 expression) or can decide to go for the normal cell cycle (On state, high E2F1 expression). Fascinatingly, if the E2F1 protein level reaches very high expression level (On state) at relatively lower GF stimulation then the cells can even commit for apoptosis [1, 2] . However, an intermediate high expression level of E2F1 (between On state of normal cell cycle and apoptosis cases) maintained for an in-between threshold GF level can eventually lead to uncontrolled cellular proliferation or cancer [2] . Thus, finding out means to control the E2F1 dynamics in and around G 1 /S transition can be crucial from the therapeutic point of view.
In this regard, exploring the role of one of the first known cancer-causing microRNAs (Oncomir1) related to the mir-17-92 cluster seems worthwhile, as these microRNAs are well-known antagonist of the E2F genes [5] [6] [7] [8] [9] [10] [11] . The mir-17-92 cluster (located on chr 13 (13q31.3) region) consists of seven different microRNAs (mir-17-5p, mir-17-3p, mir-18a, mir-19a, mir20a, mir-19b-1, and mir-92a-1), and is probably the most well-studied microRNA cluster in the literature [5] [6] [7] [8] [9] [10] . Several microRNAs associated with the mir-17-92 cluster play decisive roles in organizing the normal development as well as the events controlling the cellular proliferation in various cell types [12] in one way or other. For example, mir-19a and mir-19b-1 had shown direct role in death and proliferation [13, 14] , whereas the ratio of mir-19:mir-92 had been found to enhance the premalignant and malignant phenotypes Abbreviations GF, growth factor; SNPs, single nucleotide polymorphisms; WT, wild-type.
suggesting a role of negative regulator of mir-92 [15, 16] . At the same time, mir-20a and mir-17-5p play crucial role in antiapoptotic and antiproliferative signaling by down-regulating the E2F proteins [5, 12, 17, 18] . This indicates that the regulations imposed by the mir-17-92 cluster components in the context of proliferation are extremely diverse and complex.
Like all the other microRNAs, the members of the mir-17-92 cluster function post-transcriptionally by forming complexes with the mRNAs of different target genes like E2F to either degrade or to reduce the translational efficiency of the corresponding target mRNAs [2, 19] . This seems to suggest that down regulating mir-17-92 cluster components may lead to unwanted cell cycle entry or cancer (as E2F levels will be high) at a lower threshold level of GF, which was indeed observed for many hematopoietic cancers [5, 12, 17, 18] . Interestingly, for different solid-type cancers (and for some hematopoietic cancers as well), the microRNAs of the mir-17-92 cluster were found to be mostly overexpressed [12, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . This indicates that in solid cancer cells, the expression level of E2F must increase with the increasing level of microRNAs related to mir-17-92 cluster. In this article, we want to rationalize this mir-17-92 cluster-mediated differential dynamics of E2F protein in different cancer types, as it may provide us with crucial insights to prevent uncontrolled cellular proliferation and unwanted apoptosis events in a cell type-dependent manner.
Disentangling the influence of mir-17-92 cluster on the cell type-specific differential dynamics of E2F is not a straightforward problem. In fact, in mammalian cells, if we only focus on the mir-17-92 clustermediated E2F1 dynamics, we will observe that it is tightly regulated by a number of feedback loops operative within a core network of Myc/E2F1/mir-17-92 [1, 2, [36] [37] [38] (Fig. 1) . It is well known that E2F1 can positively regulate its own as well as Myc transcription [2, 38] . Figure 1 further depicts that both Myc and E2F1 can act as transcription factors for several microRNAs of mir-17-92 cluster, which in turn inhibit E2F1 [2, 10, [39] [40] [41] [42] . This clearly suggests that in mammalian cells, either with or without mutation (or nonfunctional form) of Rb (Retinoblastoma protein, the main antagonist of E2F1), the cell fate decisions during G1-S transition can be modified by altering the expression level of mir-17-92 cluster-related microRNAs. Still the question remains, how overexpressing mir-17-92 cluster-related microRNAs can fine-tune the dynamics of the Myc/E2F1/mir-17-92 network to generate differential activation dynamics of E2F1 in different cancer cell types?
In this article, we propose a mathematical model for the Myc/E2F1/mir-17-92 network illustrated in the Fig. 1 to resolve this important question. Our model reconciles the differential nature of the E2F1 dynamics under the overexpression condition of mir-17-92 cluster in a cancer cell type-dependent fashion. The deterministic two-dimensional bifurcation analysis of the model further substantiates why such differential E2F1 dynamics arises upon subtle alteration of the properties related to microRNAs of the mir-17-92 cluster. The model reproduces several experimental observations for cancer cell types of different origins as the expression level of mir-17-92 cluster is changed, and makes interesting experimentally testable predictions. We believe that our model essentially captures the circumstances under which mir-17-92 cluster behaves either as oncogene or as a tumor suppressor in a context-dependent manner.
Materials and methods
To develop our mathematical model, we have expanded the minimal gene regulatory network of Myc/E2F1/mir-17-92 shown in Fig. 1 by incorporating the crucial interactions based on existing experimental literature (Fig. 2) . The model depicts that the GF activates the transcription of the Myc mRNA (Myc m ) and Myc m in turn produces Myc protein (Myc p ). The Myc p positively activates the transcription of both mir-17-92 cluster component (mir) and E2F1 mRNA (E2F1 m ). It is well established in the literature that E2F1 can only positively affect the transcription of its target genes if it forms a hetero-dimeric complex (DE) with the Dp protein (Dp1 p ) [36, 38] .
We have introduced this transcriptional positive feedback by the DE complex in the Myc m , mir, and E2F1 m dynamics by using a phenomenological (Hill kinetic) term to represent the complex nature of the transcriptional activations in general. We have considered that both the Myc and E2F1 mRNAs and the corresponding proteins degrade with rates as observed in experiments [36, [43] [44] [45] [46] [47] . Figure 2 further describes that mir-17-92 cluster component (mir) provides a negative feedback to the E2F1 dynamics by forming a complex (Mpi) with the E2F1 m . From this complex (Mpi), the E2F1 m gets degraded, and the translation efficiency of E2F1 m also gets reduced compare to its free form.
We have translated the regulatory network shown in Fig. 2 into an ordinary differential equation-based mathematical model ( Table 1) . The model includes conservation relations that are generally used to obtain the concentrations of free proteins, mRNAs, and mir [48, 49] . The variables are defined in Table S1 , and the definitions of the parameters along with their numerical values are provided in Table S2 . We have acquired some of the parameter values directly from experimental literature [1, 36, [43] [44] [45] [46] [47] 50] (shown in Table S2 ).
It is worthwhile to mention that here we mainly focus to understand the emergent dynamic behavior of the regulatory network described in Fig. 2 to unravel the differential manner of E2F1 activation in cell type-specific manner as a function of varying expression level of mir-17-92 cluster component (mir). Thus, we have intuitively chosen the remaining parameters in the model in such a way that it allows us to explore the effect of different feedback loops present in the network by maintaining reasonable expression levels of all the mRNAs and proteins involved in the network.
The complete gene regulatory network ( Fig. 2 ) was constructed in terms of seven ordinary differential equations. The deterministic bifurcation analysis of the model was executed using the freely available software XPP-AUT. The bifurcation diagrams and time profiles were drawn in Origin Lab using the data points generated by XPP-AUT.
Results
E2F1 dynamics is indeed differentially regulated by mir-17-92 cluster components in a cell typespecific manner
To begin with, the bifurcation analysis of the model (Table 1 ) produces a typical bistable dynamics for the total E2F1 protein as a function of the GF that represents a wild-type (WT, Fig. 3A ) situation. The bistable dynamics ensures that the normal cell experiences a certain threshold of GF level to commit faithfully from the low level of E2F1 level (OFF state) to the higher E2F1 level (ON state) for the active proliferation cycle. An increase in the expression level of mir (situations (ii) and (iii) in Fig. 3A ) not only increases the E2F1 level in the ON state but also makes the cells more susceptible for unwanted proliferation by simultaneously reducing (shifts the saddle node SN 1 to the left of WT situation) the threshold requirement of GF. Expectedly, repression of mir (situation (i) in Fig. 3A ) further increases the threshold requirement of GF (compared to WT). At this point, we fixed the GF level to 1 s.u., and showed ( Fig. 3B ) that for a cell type represented by a parameter set provided in Table S2 , the steady-state level of total E2F1 will increase with the increasing level of mir expression level. Figure 3A ,B resembles the kind of dynamics one observes in the cases of solid tumor cancer cells [12, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] .
The question remains, how we can reverse the phenomenon keeping the same structure of the Myc/ E2F1/mir-17-92 network. In this endeavor, we performed the bifurcation analysis after only changing the kinetic parameter k dmp (from 0.01 h À1 to 0.15 h À1 ) that represents the rate at which mir facilitates the degradation of the E2F1 mRNA from the Mpi complex. In Fig. 3C , the WT again represents the bistable switching E2F1 protein dynamics as a function of GF for a WT situation of another specific cell type. Interestingly, an increase in the mir expression level now reduces the E2F1 steady-state level (situations (ii) and (iii) in Fig. 3C ) in the ON state by even creating a Table S2 , with only
higher threshold value of GF for reaching the ON state as well. On the other hand, a decrease in the mir expression ( Fig. 3C(i) ) is elevating the propensity for proliferation by reducing the threshold requirement of GF. The bifurcation diagram (Fig. 3D ) of total E2F1 as a function of basal synthesis rate of mir further indicates that for a fixed GF level (2 s.u.), the increasing expression level of mir will decrease the E2F1 in this scenario. This fits the experimental observations found in some hematopoietic cancer cell types as well as for cells, where the mir-17-92 cluster components are found to act in an antiapoptotic manner [5, 12, 17, 18] . At this point, it is worth mentioning that Aguda et al. had previously proposed a similar network as depicted in our Fig. 1 , but analyzed even a simpler version of it (by considering the effect of E2F1 and Myc together in the variable 'P') by constructing a phenomenological mathematical model [2] . The steadystate analysis of their model gives a relation l s ¼ 1 þ / s , where l s is the steady-state dimensionless concentration of E2F1 and φ s is the steady-state dimensionless concentration of miR cluster variable. This clearly shows that using the simple model proposed by Aguda et al. [2] , one can only demonstrate that E2F1 steady-state level will either increase or decrease with subsequent increase of or decrease of the mir cluster component level. Thus, using their simple model it is not possible to show that mir-20a and mir-17-5p are antiapoptotic in nature, as under these circumstances, down-regulation of these mirs will lead to increase in the steady-state E2F1 concentrations in many cell types. We have explicitly modeled the extended version of our Fig. 1 as depicted in Fig. 2 , and have captured the effect of appropriate variations in the E2F1 steady-state dynamics under different expression levels of mir-17-92 cluster component in a cell type-dependent manner (Fig. 3) .
The model validates the cell type-dependent differential dynamics of E2F1 Next, we tried to validate our model outputs with the experimentally known phenotypes under two different scenarios discussed in the previous section. Cloonan et al. [51] have shown that only overexpressing a single microRNA (mir-17-5p) related to mir-17-92 cluster is sufficient to drive the HEK293T cells (solid tumor) into high level of proliferation.
The MTT assay performed by them [51] revealed that the HEK293T cells became highly proliferative when mir-17-5p was stably overexpressed. At the same time, qRT-PCR experiment confirmed that the E2F1 expression level also increases significantly at the mRNA level [51] . Our model simulations (with k dmp 0.01 h À1 ) predict that in comparison to the WT case, overexpressing the mir-17-92 component elevates the level of E2F1 mRNA (Fig. 4A, left panel) up to an extent observed in the experiments [51] . Interestingly, the temporal evolution dynamics of E2F1 protein (Fig. 4A, right panel) under mir-17-92 overexpression condition seems to correlate nicely with proliferation profile observed in the MTT assay performed by Cloonan et al. [51] .
On the other hand, it has been observed experimentally in case of HeLa cells [40] , transient overexpression of the mir-17-92 cluster has little or no effect on the E2F1 mRNA expression, but it decreases the E2F1 protein expression by about 50%. Our model simulations (with k dmp 0.15 h À1 ) suggest that the E2F1 protein level can be reduced to 50% of that of the WT situation by overexpressing the mir-17-92 level (Fig. 4B, right panel) . Under the same condition, the mRNA level of the E2F1 shows very little effect (Fig. 4B, left panel) . This further emphasizes that mir-17-92 can either enhance or reduce the extent of proliferation by just differentially altering the E2F1 dynamics in a cell type-dependent fashion.
Two-parameter bifurcation analysis unravels the dynamical origin of differential dynamics of E2F1
In Figs 3 and 4 , we have shown that just by altering k dmp i.e., the microRNA-mediated degradation rate of E2F1 mRNA, it is possible to rationalize the differential E2F1 dynamics. To understand how the changes in the parameter k dmp affects such an interesting dynamical transition, we performed a two-parameter bifurcation analysis of the model ( Table S2 ). , as now with increasing level of GF, the mir-17-92 down-regulated phenotype or the green line will appear even before the WT case (blue line). Consequently, the mir-17-92 downregulated phenotype will commit to proliferation even at lower level of GF compare to the WT (as observed in some cases of hematopoietic cancer [5, 12, 17, 18] ).
We have shown further that even by altering the translational efficiency (k ep2 ) of the mir-17-92 bound E2F1 mRNA (Fig. S1) , the cell type-dependent E2F1 dynamics can also be reconciled. The important question one can ask is whether it is possible to manipulate either k dmp or k ep2 experimentally to influence the cell fate decision-making process or not? In our model, the way we modeled the microRNA and E2F1 mRNA interaction is quite simplified in nature. In literature it is already established that microRNAs need the presence of Argonaute proteins (especially Ago2 protein in mammalian cells) to either degrade mRNAs following different degradation pathways or even reducing the translational efficiency of the mRNAs by localizing them into P-bodies [52] . It is quite possible that the expression level of Ago2 protein is different in HEK293T and HeLa cell lines, which can essentially manifest different values for the k dmp or k ep2 in a cell type-specific manner. Thus, by either overexpressing or knocking down the Ago2 protein depending on the cell type, we can influence the commitment toward proliferation by altering the E2F1 dynamics.
Myc gene-related phenotypes could be reconciled for different levels of mir-17-92
Our minimal model of Myc/E2F1/mir-17-92 network is constructed in such a way that it allows us to investigate the importance of the Myc in the network. Experimentally it has been observed that for conditional lymphoma and leukemic cell lines, overexpressing the microRNAs from mir-17-92 cluster can rescue the cells where, Myc gene expression is temporarily inactivated upon doxycycline treatment [53] . Our model simulation (Fig. 6A, upper panel) shows that once the Myc gene expression is switched off, the relative E2F1 protein expression level falls off very rapidly in 3-4 days time as observed in the experiments [53] for the control cells kept under a basal GF medium. Intriguingly, if the mir-17-92 is overexpressed in the model as soon as the Myc gene is repressed, the relative E2F1 protein level seems to increase gradually (Fig. 6A, lower panel) with time corroborating the experimental findings [53] .
Our model further describes a Myc phenotype, which is even more challenging to envisage. It has been displayed experimentally [47] that overexpressing Myc gene systematically in serum starved REF52 cells containing a d2GFP reporter driven by E2F1 promoter produces a unique phenotype where, for very low and very high level of Myc gene expression, one can have relatively low level of E2F1 protein expression, but a moderate level of Myc expression leads to high expression level of E2F1. The steady-state analysis of our model suggests that for such serum starved cells (kept under GF = 0.0001 s.u.), the E2F1 steady state will produce a mushroom-like bifurcation (Fig. 6B) as a function of the basal synthesis rate of the Myc.
This evidently shows why for very low and very high expressions of Myc mRNA, a low steady-state level of E2F1 expression can be achieved, while a moderate level of Myc will lead the dynamical system to the higher expressing E2F1 steady state.
Sensitivity analysis reveals ways to influence the cell type-dependent proliferation response ) by taking the positions of SN 1 and SN 2 as the sensitivity parameter to explore the possible ways to influence the cell typedependent proliferation by adjusting the E2F1 dynamics. Our intention was to figure out the other parameters by altering which we can affect the proliferation response in a cell type-specific manner.
A careful inspection of the sensitivity analysis diagrams (Figs S2-S5) allowed us to separate out the parameters (as summarized in Fig. 7A,B) , which would have differential impact on the respective saddle nodes for the two chosen values of k dmp . Interestingly, all the parameters that appear in Fig. 7 , in one way or other are related to the mir-17-92 cluster component, and one of them is indeed the b mir . Figure 7 opens up a set of experimental possibilities to change the fate of a proliferating cell just by manipulating the E2F1 dynamics. For example, depending on the requirement, (i) the k dmr can be altered by producing a more or less stable variant of microRNA, (ii) k mp1 can be varied experimentally to reduce the association propensity of mir and mRNA of E2F1, and (iii) k mr1 and k mr2 can be manipulated by blocking the transcription initiation sites or reducing the level of other transcriptional coactivator required for mir production. Thus, the model qualitatively predicts a set of selective routes to control the proliferation by just perturbing the Myc/ E2F1/mir-17-92 network. We further explore computationally the possible phenotypic outcomes if the parameter k mp1 is varied in a cell type-specific way. The model predicts (for k dmp = 0.01 h À1 situation, i.e., with lower expression level of Ago2 protein) if the k mp1 is reduced than the WT situation, then the corresponding cells will require higher doses of GF to transit to the higher steady-state level of E2F1 (Fig. 7C ). This qualitatively suggests that under this parametric condition the cells will be pushed more toward quiescent state, as it stays in the lower steady state of E2F1 for higher values of GF (compare to WT case). However, an increase in the k mp1 value will lead to different kinds of phenotype, where the cells are transiting to even higher steady-state level of E2F1 protein (this might push the cells toward apoptosis) at much lower level to GF (earlier transition to highly proliferative state might lead to cancerous phenotype) compare to the WT situation. Figure 7D essentially foretells that the observations made for the cell types having intrinsically higher expression level of Ago2 protein, i.e., higher value of k dmp (for k dmp = 0.15 h À1 situation) will be exactly opposite in nature if we increase or decrease the value of k mp1 (compare to Fig. 7C ). Interestingly, there is more than one way to alter the parameter k mp1 experimentally. The binding affinity between mir and the E2F1 mRNA can be achieved by modulating either the target E2F1 mRNA or preferably by introducing changes in the corresponding mir through genetic, epigenetic, and transcriptional mechanisms. In mammalian cells, single nucleotide polymorphisms (SNPs) happen quite frequently and can cause fatal disease phenotypes [54] [55] [56] [57] [58] [59] . This kind of SNPs can be introduced to the corresponding mir to disrupt the mir and E2F1 mRNA binding as found in other biological systems. Intriguingly, sometimes SNPs might introduce new binding sites in mir that might increase the binding (Table S2) Table S2 ,
affinity with the target mRNA. Additionally, the binding affinity (k mp1 ) between mir and target E2F1 mRNA can be altered by (i) generating alternative 3 0 UTRs in target mRNAs through alternative splicing or polyadenylation, (ii) regulating the secondary structure of mRNA by changing the concentration of RNA-binding proteins, and (iii) using other competing noncoding RNAs (ncRNA) [54] [55] [56] [57] [58] [59] [60] [61] [62] .
Discussion and Conclusions
In many cancerous cells, the principle inhibitor of E2F1, i.e., the Retinoblastoma protein (Rb) remains either as mutated or nonfunctional [22] . Under such a condition, the microRNAs related to mir-17-92 can play decisive role in directing the cells toward either cellular proliferation or apoptosis or even in some cases to quiescence by controlling the E2F1 dynamics. Thus, mir-17-92 can act as oncogene as well as tumor suppressor depending on the cell type [2, 5, 12, 17, 18, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . To understand the intricacies of the interactions between E2F1, Myc, and microRNAs related to mir-17-92 cluster, we proposed and investigated a relatively simple Myc/E2F1/mir-17-92 network (Fig. 2) . Our model essentially captures all the positive and negative feedback interactions that are responsible for the bistable E2F1 dynamics observed in mammalian cells. The 1-D bifurcation analysis (Fig. 3) of our model qualitatively depicts the experimentally observed differential dynamics of E2F1 protein (as a function of GF) under different mir expression levels. This not only corroborates (Fig. 4 ) with the experimental findings for different solid cancers but also supports the experiments, where overexpressing mir-20a and mir-17-5p caused increased level of apoptosis [12, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . In the latter case, the experiments further suggest that the apoptosis is caused due to increased expression of E2F1 protein upon down-regulating the mir-20a and mir-17-5p [39] . Importantly, the 2D-bifurcation diagrams ( Fig. 5  and Fig. S1B ) reveal the one of the probable routes by which the reversal of the E2F1 steady-state dynamics can be achieved under overexpressing condition of mir, and how it can be realized by just altering the k dmp or k ep2 . Intriguingly, the sensitivity analysis (Fig. 7) of the model uncovers that the reversal of the E2F1 dynamics can only be accomplished by changing the mir-17-92 related parameters. We further discussed how one could perform experiments at different levels to test these predictions. In this context, it is worthwhile mentioning that our model definitely improves the current understanding about the Myc/E2F1/mir-17-92 network than the previous model proposed by Aguada et al. [2] . Although their model was a simpler one compare to us, but it failed to portray how the steady-state behavior of E2F1 protein can vary in an opposite manner (as a function of GF) as the mir is overexpressed in a cell type-dependent manner. Importantly, in our proposed detailed model (Table 1) , it is possible to up-regulate or down-regulate the level of mir-17-92 component (as observed experimentally) computationally by tuning the levels of inhibition efficiency of mir-17-92 toward E2F1 mRNA. In Aguda et al. model [2] , all these factors (i.e., the expression level of mir cluster and inhibition efficiency) were clubbed up in a single variable, thus it will not be possible to tune their model to observe the differential proliferation pattern (in terms of steady-state level of E2F1) just by altering the expression level of mir cluster. Not only that, our model has a broader applicability, as it also adequately explains the Myc-related mutants (Fig. 6 ) under different expression levels of mir [47, 53] .
To conclude, our proposed model effectively replicates the mir-17-92 influenced steady-state dynamics of E2F1 in a cell type-dependent manner. It predicts qualitatively how one can manipulate the mir-related part of the Myc/E2F1/mir-17-92 network to push a particular cancerous cell to either quiescence or apoptosis. Thus, it provides important insights to utilize the oncogenic or tumor suppressor behavior of mir-17-92 cluster in a context-dependent manner for developing novel therapeutic strategies to treat uncontrolled proliferation.
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